| |
| |
|
| Insider
Information: |
Kramlich C Richard |
| Relationship: |
10% Owner |
| City: |
Baltimore |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
16 |
|
| Direct
Shares |
28,112 |
|
|
Indirect Shares
|
132,029,754 |
|
|
| Direct
Value |
$15,848 |
|
|
|
Indirect Value
|
$184,567,087 |
|
|
| Total
Shares |
132,057,866 |
|
|
| Total
Value |
$184,582,935 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -60.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
DZS Inc |
DZSI |
Director |
2017-09-09 |
9,326 |
2011-05-10 |
4,781,273 |
Premium* |
|
|
SVB Financial Group |
SIVB |
Director |
2015-04-23 |
17,969 |
2007-05-14 |
5,913 |
Premium* |
|
|
Sierra Monitor Corp /ca/ |
SRMC |
Director |
2019-05-20 |
0 |
2012-06-13 |
211,500 |
Premium* |
|
|
Gyre Therapeutics |
GYRE |
10% Owner |
2006-04-12 |
0 |
2012-11-19 |
4,568,845 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2006-05-15 |
0 |
2009-01-30 |
2,083,426 |
Premium* |
|
|
Vonage Holdings Corp |
VG |
10% Owner |
2006-05-30 |
0 |
2011-03-11 |
22,793 |
Premium* |
|
|
Innerworkings Inc |
INWK |
10% Owner |
2012-03-28 |
729 |
2012-03-28 |
15,000 |
Premium* |
|
|
Amicus Therapeutics Inc |
FOLD |
10% Owner |
2007-06-05 |
0 |
2012-03-07 |
4,584,311 |
Premium* |
|
|
Inteliquent Inc |
IQNT |
10% Owner |
2009-02-20 |
88 |
2009-02-20 |
1,882,204 |
Premium* |
|
|
Echo Global Logistics Inc |
ECHO |
10% Owner |
|
0 |
2012-02-28 |
901 |
Premium* |
|
|
Financial Engines, Inc. |
FNGN |
Director |
|
0 |
2010-11-16 |
688,871 |
Premium* |
|
|
Groupon, Inc. |
GRPN |
10% Owner |
|
0 |
2011-11-03 |
87,184,956 |
Premium* |
|
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2011-11-21 |
0 |
2011-11-21 |
3,419,671 |
Premium* |
|
|
Millennial Media Inc |
MM |
10% Owner |
2012-04-03 |
0 |
2012-10-29 |
8,196,614 |
Premium* |
|
|
Tesaro, Inc. |
TSRO |
10% Owner |
2012-07-03 |
0 |
2012-07-03 |
11,499,255 |
Premium* |
|
|
Hyperion Therapeutics Inc |
HPTX |
10% Owner |
|
0 |
2012-07-31 |
2,884,221 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
285 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 11 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DZSI |
DZS Inc |
Director |
– • – |
2004-05-19 |
4 |
A |
$3.24 |
$4,999 |
D/D |
1,543 |
1,543 |
|
- |
|
| SRMC |
Sierra Monitor Corp /ca/ |
Director |
– • – |
2019-05-20 |
4 |
D |
$3.25 |
$8,994,986 |
D/D |
(2,767,688) |
0 |
0 |
- |
|
| DZSI |
DZS Inc |
Director |
– • – |
2004-05-06 |
4 |
B |
$3.35 |
$840,248 |
I/I |
251,000 |
1,361,032 |
2.1 |
- |
|
| DZSI |
DZS Inc |
Director |
– • – |
2004-05-07 |
4 |
B |
$3.41 |
$781,921 |
I/I |
229,000 |
1,590,032 |
2.1 |
- |
|
| DZSI |
DZS Inc |
Director |
– • – |
2004-04-29 |
4 |
B |
$3.45 |
$912,947 |
I/I |
264,400 |
860,032 |
2.1 |
- |
|
| DZSI |
DZS Inc |
Director |
– • – |
2004-04-28 |
4 |
B |
$3.47 |
$1,756,353 |
I/I |
505,600 |
595,632 |
2.1 |
- |
|
| DZSI |
DZS Inc |
Director |
– • – |
2013-12-12 |
4 |
S |
$4.47 |
$22,013 |
D/D |
(4,927) |
379 |
0 |
- |
|
| DZSI |
DZS Inc |
Director |
– • – |
2013-12-11 |
4 |
S |
$4.55 |
$175,524 |
D/D |
(38,597) |
5,306 |
0 |
- |
|
| DZSI |
DZS Inc |
Director |
– • – |
2013-12-05 |
4 |
S |
$5.01 |
$113,376 |
D/D |
(22,630) |
43,903 |
0 |
- |
|
| DZSI |
DZS Inc |
Director |
– • – |
2013-12-06 |
4 |
S |
$5.28 |
$241,407 |
D/D |
(45,747) |
43,903 |
0 |
- |
|
| DZSI |
DZS Inc |
Director |
– • – |
2013-11-26 |
4 |
S |
$5.41 |
$562,142 |
D/D |
(103,261) |
43,903 |
0 |
- |
|
| DZSI |
DZS Inc |
Director |
– • – |
2013-11-25 |
4 |
S |
$5.46 |
$53,842 |
D/D |
(9,854) |
83,080 |
0 |
- |
|
| DZSI |
DZS Inc |
Director |
– • – |
2013-11-27 |
4 |
S |
$5.46 |
$15,282 |
D/D |
(2,800) |
43,903 |
0 |
- |
|
| DZSI |
DZS Inc |
Director |
– • – |
2013-12-02 |
4 |
S |
$5.48 |
$31,944 |
D/D |
(5,826) |
43,903 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
10% Owner |
– – • |
2012-03-07 |
4 |
B |
$5.70 |
$6,498,000 |
I/I |
1,140,000 |
4,584,311 |
1.5 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
10% Owner |
– – • |
2007-06-05 |
4 |
OE |
$6.38 |
$96,116 |
I/I |
15,077 |
3,665,565 |
0 |
- |
|
| DZSI |
DZS Inc |
Director |
– • – |
2004-02-06 |
4/A |
A |
$6.41 |
$1,018,152 |
I/I |
158,838 |
104,230 |
0 |
- |
|
| DZSI |
DZS Inc |
Director |
– • – |
2004-02-06 |
4 |
A |
$6.41 |
$879,458 |
I/I |
137,201 |
90,032 |
|
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
– – • |
2006-05-15 |
4 |
B |
$6.50 |
$7,499,999 |
I/I |
1,153,846 |
4,900,715 |
1.5 |
- |
|
| GYRE |
Gyre Therapeutics |
10% Owner |
– – • |
2008-01-17 |
4 |
A |
$7.07 |
$9,191,000 |
I/I |
1,300,000 |
4,563,512 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
10% Owner |
– – • |
2006-04-12 |
4 |
B |
$9.00 |
$3,150,000 |
I/I |
350,000 |
350,000 |
1.5 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
10% Owner |
– – • |
2012-07-31 |
4 |
B |
$10.00 |
$5,000,000 |
I/I |
500,000 |
2,884,221 |
1.5 |
- |
|
| INWK |
Innerworkings Inc |
10% Owner |
– – • |
2012-02-24 |
4 |
S |
$11.40 |
$3,812,810 |
I/I |
(334,457) |
6,484,550 |
0 |
- |
|
| INWK |
Innerworkings Inc |
10% Owner |
– – • |
2012-02-29 |
4 |
S |
$11.42 |
$5,199,164 |
I/I |
(455,360) |
6,029,190 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
10% Owner |
– – • |
2007-07-25 |
4 |
A |
$11.49 |
$338,452 |
I/I |
29,447 |
851,183 |
0 |
- |
|
285 Records found
|
|
Page 11 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
